Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Debt Repaid

Rigel Pharmaceuticals Debt Repaid Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Debt Repaid from 2010 to 2011.
  • Rigel Pharmaceuticals Debt Repaid for the quarter ending December 12, 2011 was $0m a -87.31% increase of 0m year over year
  • Rigel Pharmaceuticals Debt Repaid for the last 12 months ending September 09, 2012 was $0m a -497.01% increase of 1m year over year
  • Rigel Pharmaceuticals Annual Debt Repaid for 2011 was $-1m a -43.00% increase of 0m from 2010
  • Rigel Pharmaceuticals Annual Debt Repaid for 2010 was $-1m
Other Cash Flow Metrics:
  • Rigel Pharmaceuticals Cash Flow from Operations for the quarter ending December 12, 2018 was $12m a 300.91% increase of 35m year over year
  • Rigel Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $1m a 1,495.75% increase of 15m year over year
  • Rigel Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $5m a 26.33% increase of 1m year over year
View Chart On Koyfin

Quarterly RIGL Debt Repaid Data

12/2011$0m
09/2011$0m
06/2011$0m
03/2011$0m
12/2010$0m
09/2010$0m
06/2010$0m
03/2010$0m

Annual RIGL Debt Repaid Data

2011$-1m
2010$-1m